Abiopharma

News list

Bellar Lonnie E 🟡 adjusted position in 37 shares (1 derivative) of PPL Corp (PPL) at $38.75 Transaction Date: Apr 24, 2026 | Filing ID: 186999

Full text

News bot April 28, 2026, 8:08 p.m.
🔍 Bellar Lonnie E (Executive)

Company: PPL Corp (PPL)

Report Date: 2026-04-24
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 81
- Total shares sold: 118
Detailed Transactions and Holdings:
- Acquired 81 shares of Common Stock at $38.75 per share (Direct)
  Date: 2026-04-24 | Code: M | equity_swap_involved: false | shares_owned_after: 42,242.45 | transaction_form_type: 4
- Sold 37 shares of Common Stock at $38.75 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: false | shares_owned_after: 42,205.45 | transaction_form_type: 4 | Footnotes: F1
- Sold 81 shares of Stock Unit (SIP) (Derivative)
  Date: 2026-04-24 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F3, F3, F2
Footnotes:
- F1: Shares withheld by the company at the request of the executive officer to pay taxes due following expiration of the applicable restriction period, under the terms of the Stock Incentive Plan (SIP).
- F2: Total includes the reinvestment of dividends.
- F3: The units vested on 04/24/2026 as the first installment of the restricted stock units granted on 04/25/2025. The remainder of the total grant of 245.380 restricted stock units will vest in two subsequent installments on 04/25/2027 (81.449 shares) and 04/25/2028 (82.482 shares).